Infectious Diseases Society of America (English Wikipedia)

Landers, Susan J (2008-06-09). "Lyme treatment accord ends antitrust probe". American Medical News. Archived from the original on 2008-06-11. Retrieved 2008-06-24.

archive.today

Whelan, David (2007-03-12). "Lyme Inc". Forbes. Archived from the original on 2007-05-03. Retrieved 2008-06-24.

cdc.gov

"Post-Treatment Lyme Disease Syndrome". Centers for Disease Control and Prevention. 2019-11-08. Archived from the original on 2017-06-17. Retrieved 9 June 2021.

doi.org

Spellberg, Blaser, Guidos; et al. (May 2011). "Combating Antimicrobial Resistance: Policy Recommendations to Save Lives". Clin. Infect. Dis. 52 (suppl 5): S397 – S428. doi:10.1093/cid/cir153. PMC 3738230. PMID 21474585.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Boucher, Helen; Talbot, George; Benjamin, Daniel; Bradley, John; Guidos, Robert; Jones, Ronald; Murray, Barbara; Bonomo, Robert; et al. (2013). "10 X '20 Progress – Development of New Drugs Active Against Gram-Negative Bacilli: An Update From the Infectious Diseases Society of America". Clinical Infectious Diseases. 56 (12). Oxford University Press: 1685–1694. doi:10.1093/cid/cit152. PMC 3707426. PMID 23599308.
Wormser GP, Dattwyler RJ, Shapiro ED, et al. (November 2006). "The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America". Clin. Infect. Dis. 43 (9): 1089–134. doi:10.1086/508667. PMID 17029130.
Wormser, Gary P.; Strle, Franc; Shapiro, Eugene D.; Auwaerter, Paul G. (1 October 2021). "Comparison of the clinical practice guidelines for Lyme disease from the Infectious Diseases Society of America: 2000, 2006, and 2020". Diagnostic Microbiology and Infectious Disease. 101 (2): 115446. doi:10.1016/j.diagmicrobio.2021.115446. PMID 34256207.
Halperin JJ, Shapiro ED, Logigian E, Belman AL, Dotevall L, Wormser GP, Krupp L, Gronseth G, Bever CT (2007). "Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology". Neurology. 69 (1): 91–102. doi:10.1212/01.wnl.0000265517.66976.28. PMID 17522387. Archived from the original on 2009-08-04. Retrieved 2010-03-09.
Feder HM, Johnson BJ, O'Connell S; et al. (October 2007). "A critical appraisal of "chronic Lyme disease"". N. Engl. J. Med. 357 (14): 1422–30. doi:10.1056/NEJMra072023. PMID 17914043.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Klein JO (November 2008). "Danger ahead: politics intrude in Infectious Diseases Society of America guideline for Lyme disease". Clin. Infect. Dis. 47 (9): 1197–9. doi:10.1086/592247. PMID 18821849.
Kraemer JD, Gostin LO (February 2009). "Science, politics, and values: the politicization of professional practice guidelines". JAMA. 301 (6): 665–7. doi:10.1001/jama.301.6.665. PMID 19211474.

forbes.com

Whelan, David (2007-03-12). "Lyme Inc". Forbes. Archived from the original on 2007-05-03. Retrieved 2008-06-24.

homelandprepnews.com

Williams, Terri (2017-11-29). "Steep cuts to Prevention and Public Health Fund as part of House bill draws concerns". Homeland Preparedness News. Archived from the original on 2021-01-17. Retrieved 2017-12-04.
"Fewer companies support antibiotic drug research, development". Homeland Preparedness News. 2018-11-27. Archived from the original on 2021-02-26. Retrieved 2018-11-30.

idmeeting.org

"Facts About IDSA". Infectious Diseases Society of America. Archived from the original on July 26, 2011. Retrieved October 29, 2010.

idsociety.org

"Board of Directors". Infectious Diseases Society of America. Archived from the original on 8 February 2023. Retrieved 20 October 2024.
"Forming The Society". www.idsociety.org. Archived from the original on 2019-05-04. Retrieved 2019-06-16.
"IRS Form 990 for 2018" (PDF). idsociety.org. Archived (PDF) from the original on December 26, 2019. Retrieved December 26, 2019.
IDSA history Archived 2016-11-26 at the Wayback Machine – Retrieved 2017-01-25
"Antibiotic Development: The 10 x '20 Initiative". Infectious Diseases Society of America. Archived from the original on December 30, 2012. Retrieved December 12, 2012.
"Facts about Antibiotic Resistance". Infectious Diseases Society of America. Archived from the original on January 3, 2013. Retrieved December 12, 2012.
"Combating Antimicrobial Resistance: Policy Recommendations to Save Lives" (PDF). Infectious Diseases Society of America. Archived from the original (PDF) on March 16, 2014. Retrieved May 30, 2012.
"Drug Companies, Health Groups Back IDSA Proposal" (Press release). Infectious Diseases Society of America. April 12, 2012. Archived from the original on August 26, 2012. Retrieved August 12, 2012.
"Antimicrobial Resistance". Infectious Diseases Society of America. Archived from the original on May 27, 2012. Retrieved May 30, 2012.
"IDSA Final Report of the Lyme Disease Review Panel of the Infectious diseases Society of America". Archived from the original on 2012-06-29. Retrieved 2012-07-20.
"Special Review Panel Unanimously Upholds Lyme Disease Treatment Guidelines". Infectious Diseases Society of America. 22 April 2010. Archived from the original on 9 June 2021. Retrieved 9 June 2021.

ein.idsociety.org

"Emerging Infections Network". Emerging Infections Network. IDSA. Archived from the original on 1 July 2014. Retrieved 4 June 2014.

idweek.org

"IDSA Meeting Website". Infectious Diseases Society of America. Archived from the original on January 30, 2012. Retrieved January 20, 2012.

neurology.org

Halperin JJ, Shapiro ED, Logigian E, Belman AL, Dotevall L, Wormser GP, Krupp L, Gronseth G, Bever CT (2007). "Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology". Neurology. 69 (1): 91–102. doi:10.1212/01.wnl.0000265517.66976.28. PMID 17522387. Archived from the original on 2009-08-04. Retrieved 2010-03-09.

nih.gov

pubmed.ncbi.nlm.nih.gov

Spellberg, Blaser, Guidos; et al. (May 2011). "Combating Antimicrobial Resistance: Policy Recommendations to Save Lives". Clin. Infect. Dis. 52 (suppl 5): S397 – S428. doi:10.1093/cid/cir153. PMC 3738230. PMID 21474585.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Boucher, Helen; Talbot, George; Benjamin, Daniel; Bradley, John; Guidos, Robert; Jones, Ronald; Murray, Barbara; Bonomo, Robert; et al. (2013). "10 X '20 Progress – Development of New Drugs Active Against Gram-Negative Bacilli: An Update From the Infectious Diseases Society of America". Clinical Infectious Diseases. 56 (12). Oxford University Press: 1685–1694. doi:10.1093/cid/cit152. PMC 3707426. PMID 23599308.
Wormser GP, Dattwyler RJ, Shapiro ED, et al. (November 2006). "The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America". Clin. Infect. Dis. 43 (9): 1089–134. doi:10.1086/508667. PMID 17029130.
Wormser, Gary P.; Strle, Franc; Shapiro, Eugene D.; Auwaerter, Paul G. (1 October 2021). "Comparison of the clinical practice guidelines for Lyme disease from the Infectious Diseases Society of America: 2000, 2006, and 2020". Diagnostic Microbiology and Infectious Disease. 101 (2): 115446. doi:10.1016/j.diagmicrobio.2021.115446. PMID 34256207.
Halperin JJ, Shapiro ED, Logigian E, Belman AL, Dotevall L, Wormser GP, Krupp L, Gronseth G, Bever CT (2007). "Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology". Neurology. 69 (1): 91–102. doi:10.1212/01.wnl.0000265517.66976.28. PMID 17522387. Archived from the original on 2009-08-04. Retrieved 2010-03-09.
Feder HM, Johnson BJ, O'Connell S; et al. (October 2007). "A critical appraisal of "chronic Lyme disease"". N. Engl. J. Med. 357 (14): 1422–30. doi:10.1056/NEJMra072023. PMID 17914043.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Klein JO (November 2008). "Danger ahead: politics intrude in Infectious Diseases Society of America guideline for Lyme disease". Clin. Infect. Dis. 47 (9): 1197–9. doi:10.1086/592247. PMID 18821849.
Kraemer JD, Gostin LO (February 2009). "Science, politics, and values: the politicization of professional practice guidelines". JAMA. 301 (6): 665–7. doi:10.1001/jama.301.6.665. PMID 19211474.

ncbi.nlm.nih.gov

Spellberg, Blaser, Guidos; et al. (May 2011). "Combating Antimicrobial Resistance: Policy Recommendations to Save Lives". Clin. Infect. Dis. 52 (suppl 5): S397 – S428. doi:10.1093/cid/cir153. PMC 3738230. PMID 21474585.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Boucher, Helen; Talbot, George; Benjamin, Daniel; Bradley, John; Guidos, Robert; Jones, Ronald; Murray, Barbara; Bonomo, Robert; et al. (2013). "10 X '20 Progress – Development of New Drugs Active Against Gram-Negative Bacilli: An Update From the Infectious Diseases Society of America". Clinical Infectious Diseases. 56 (12). Oxford University Press: 1685–1694. doi:10.1093/cid/cit152. PMC 3707426. PMID 23599308.

www3.niaid.nih.gov

""Chronic Lyme Disease" Fact Sheet". National Institute of Allergy and Infectious Diseases. April 17, 2009. Archived from the original on March 8, 2010.

voanews.com

Sinha, Vidushi (May 17, 2010). "Antibiotic Resistance Called Growing Threat to Human Health". Voice of America News. Archived from the original on September 25, 2012. Retrieved December 12, 2012.

web.archive.org

"Board of Directors". Infectious Diseases Society of America. Archived from the original on 8 February 2023. Retrieved 20 October 2024.
"Forming The Society". www.idsociety.org. Archived from the original on 2019-05-04. Retrieved 2019-06-16.
"IRS Form 990 for 2018" (PDF). idsociety.org. Archived (PDF) from the original on December 26, 2019. Retrieved December 26, 2019.
IDSA history Archived 2016-11-26 at the Wayback Machine – Retrieved 2017-01-25
"IDSA Meeting Website". Infectious Diseases Society of America. Archived from the original on January 30, 2012. Retrieved January 20, 2012.
"Facts About IDSA". Infectious Diseases Society of America. Archived from the original on July 26, 2011. Retrieved October 29, 2010.
"Emerging Infections Network". Emerging Infections Network. IDSA. Archived from the original on 1 July 2014. Retrieved 4 June 2014.
Williams, Terri (2017-11-29). "Steep cuts to Prevention and Public Health Fund as part of House bill draws concerns". Homeland Preparedness News. Archived from the original on 2021-01-17. Retrieved 2017-12-04.
Sinha, Vidushi (May 17, 2010). "Antibiotic Resistance Called Growing Threat to Human Health". Voice of America News. Archived from the original on September 25, 2012. Retrieved December 12, 2012.
"Antibiotic Development: The 10 x '20 Initiative". Infectious Diseases Society of America. Archived from the original on December 30, 2012. Retrieved December 12, 2012.
"Facts about Antibiotic Resistance". Infectious Diseases Society of America. Archived from the original on January 3, 2013. Retrieved December 12, 2012.
"Combating Antimicrobial Resistance: Policy Recommendations to Save Lives" (PDF). Infectious Diseases Society of America. Archived from the original (PDF) on March 16, 2014. Retrieved May 30, 2012.
"Drug Companies, Health Groups Back IDSA Proposal" (Press release). Infectious Diseases Society of America. April 12, 2012. Archived from the original on August 26, 2012. Retrieved August 12, 2012.
"Antimicrobial Resistance". Infectious Diseases Society of America. Archived from the original on May 27, 2012. Retrieved May 30, 2012.
"Fewer companies support antibiotic drug research, development". Homeland Preparedness News. 2018-11-27. Archived from the original on 2021-02-26. Retrieved 2018-11-30.
Halperin JJ, Shapiro ED, Logigian E, Belman AL, Dotevall L, Wormser GP, Krupp L, Gronseth G, Bever CT (2007). "Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology". Neurology. 69 (1): 91–102. doi:10.1212/01.wnl.0000265517.66976.28. PMID 17522387. Archived from the original on 2009-08-04. Retrieved 2010-03-09.
""Chronic Lyme Disease" Fact Sheet". National Institute of Allergy and Infectious Diseases. April 17, 2009. Archived from the original on March 8, 2010.
"Post-Treatment Lyme Disease Syndrome". Centers for Disease Control and Prevention. 2019-11-08. Archived from the original on 2017-06-17. Retrieved 9 June 2021.
O'Connell, Sue. "Recommendations for diagnosis and treatment of Lyme borreliosis: guidelines and consensus papers guidelines and consensus papers from specialist societies and ex from specialist societies and expert groups in pert groups in Europe and North America Europe and North America" (PDF). Archived (PDF) from the original on 21 January 2022. Retrieved 9 June 2021.
Landers, Susan J (2008-06-09). "Lyme treatment accord ends antitrust probe". American Medical News. Archived from the original on 2008-06-11. Retrieved 2008-06-24.
"IDSA Final Report of the Lyme Disease Review Panel of the Infectious diseases Society of America". Archived from the original on 2012-06-29. Retrieved 2012-07-20.
"Special Review Panel Unanimously Upholds Lyme Disease Treatment Guidelines". Infectious Diseases Society of America. 22 April 2010. Archived from the original on 9 June 2021. Retrieved 9 June 2021.